TAGLN2 Human

Transgelin-2 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to TAGLN2 Human

TAGLN2 (Transgelin-2), a member of the calponin family, is a 208-amino acid actin-binding protein critical for cytoskeletal regulation. Expressed predominantly in immune tissues and smooth muscle, it stabilizes actin filaments through a 1:6 monomer binding ratio . Recombinant TAGLN2 is produced in E. coli with a His-tag for purification, maintaining a molecular weight of 23.4 kDa .

Tissue-Specific Expression

TAGLN2 exhibits distinct expression patterns:

Tissue TypeExpression LevelSource
Thymus/Spleen/Lymph nodesHighTCGA/GTEx
Smooth muscleEarly differentiationPROSPEC
Cancer tissuesOverexpressed (e.g., bladder, liver, breast)HPA/TCGA

In cancers, TAGLN2 mRNA is elevated in 23 tumor types, including bladder, liver, and breast carcinomas, while downregulated in renal cell carcinoma and prostate adenocarcinoma .

Role in T-Cell Activation

TAGLN2 stabilizes cortical F-actin at the immunological synapse, enabling T-cell adhesion and cytokine production:

  • Mechanism:

    • Blocks actin depolymerization via cofilin competition .

    • Maintains F-actin integrity during antigen recognition .

  • Functional Impact:

    • TAGLN2 knockout mice show reduced IL-2/IFN-γ secretion and impaired cytotoxicity .

    • Overexpression enhances T-cell responses to ovalbumin peptides .

Oncogenic Potential and Prognostic Value

TAGLN2 is implicated in tumor progression:

Cancer TypeGenetic AlterationPrognostic Impact
Bladder UrothelialAmplificationPoor prognosis
Liver HepatocellularAmplificationTumor growth promotion
Breast InvasiveAmplificationMetastasis correlation
GlioblastomaOverexpressionReduced survival

Key Findings:

  • Genetic alterations: Amplification is the dominant change across cancers .

  • Epigenetic regulation: DNA hypomethylation correlates with increased expression .

  • Prognostic marker: Elevated TAGLN2 predicts adverse outcomes in bladder, breast, and glioblastoma .

Functional Insights in Immune Regulation

Beyond T-cells, TAGLN2 modulates actin dynamics in phagocytosis and immune synapse formation . Its upregulation in colorectal, hepatocellular, and lung cancers suggests a dual role in immune evasion and tumor progression .

Clinical and Therapeutic Implications

TAGLN2’s role in immune activation and oncogenesis positions it as a potential therapeutic target:

  • Cancer therapy: Inhibiting TAGLN2 may reduce tumor angiogenesis and invasion .

  • Immune modulation: Enhancing TAGLN2 activity could improve antitumor immunity .

Product Specs

Introduction
Transgelin 2 (TAGLN2), an early marker of differentiated smooth muscle, contains a calponin-like repeat and a calponin-homology (CH) domain. Downregulation of TAGLN2 is observed in certain transformed cell lines, suggesting its reduced expression as a potential early indicator of transformation. TAGLN2 exhibits actin-binding properties, inducing gelation of actin fibers within minutes of interaction. This binding occurs at a ratio of 1:6, with one TAGLN2 molecule binding to six actin monomers.
Description
Recombinant human TAGLN2, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein, with a molecular weight of 23.4 kDa, consists of 208 amino acids (13-199 a.a.) and includes a 21 amino acid His tag at the N-terminus. Purification of TAGLN2 is achieved through proprietary chromatographic methods.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
TAGLN2 is provided as a 1 mg/ml solution in 20mM Tris-HCl buffer (pH 8.0), containing 20% glycerol, 0.1M NaCl, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of TAGLN2 is determined to be greater than 90.0% based on SDS-PAGE analysis.
Synonyms
Transgelin-2, SM22-alpha homolog, TAGLN2, KIAA0120, HA1756.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MEVQQKIEKQ YDADLEQILI QWITTQCRKD VGRPQPGREN FQNWLKDGTV LCELINALYP EGQAPVKKIQ ASTMAFKQME QISQFLQAAE RYGINTTDIF QTVDLWEGKN MACVQRTLMN LGGLAVARDD GLFSGDPNWF PKKSKENPRN FSDNQLQEGK NVIGLQMGTN RGASQAGMTG YGMPRQIL.

Q&A

What is TAGLN2 and how does it differ from other transgelin family members?

TAGLN2 is a 22-kDa actin-binding protein belonging to the transgelin family, which includes three isoforms with high sequence identity (~80%): TAGLN1, TAGLN2, and TAGLN3. While TAGLN1 (SM22α) is predominantly expressed in smooth muscle cells and TAGLN3 (NP25) is abundant in brain tissues, TAGLN2 is uniquely expressed in lymphocytes and certain non-smooth muscle cells . The term "transgelin" derives from the transformation-sensitive and rapid actin-gelling properties of these proteins . TAGLN2 contains a calponin homology (CH) domain and an actin-binding motif (ABM) between residues 153-160, which are essential for its interaction with actin filaments .

What is the structural basis for TAGLN2's interaction with actin?

TAGLN2 contains specific structural domains that mediate its interaction with actin:

  • A calponin homology (CH) domain - evolutionarily related to those found in other cytoskeletal regulatory proteins like Vav1 and IQGAP1

  • An actin-binding motif (ABM) located between residues 153-160

These structural elements enable TAGLN2 to bind directly to F-actin in a stimulus-independent manner . The binding of TAGLN2 to actin monomers reaches saturation at a 1:1 ratio, indicating a stoichiometric interaction . Deletion of the ABM (ΔABM) significantly reduces TAGLN2's association with F-actin and eliminates its actin-stabilizing activity, demonstrating that this motif is essential for TAGLN2's function .

How is TAGLN2 expression regulated in immune cells?

TAGLN2 is highly expressed in immunogenic tissues and immune cells. Northern blot analysis has shown high expression in the spleen, while Western blot and real-time quantitative PCR analyses confirmed that TAGLN2 is most abundantly expressed in the thymus, spleen, and lymph nodes . In macrophages, TAGLN2 expression is significantly induced in response to lipopolysaccharide (LPS), a ligand for Toll-like receptor 4 (TLR4), partly through the NF-κB signaling pathway . This induction suggests that TAGLN2 expression can be dynamically regulated during immune responses, particularly in the context of bacterial infection.

How does TAGLN2 contribute to immunological synapse formation in T cells?

TAGLN2 plays a critical role in immunological synapse (IS) formation through its ability to stabilize cortical F-actin. When T cells are activated:

  • TAGLN2 becomes segregated at the distal supramolecular activation cluster (d-SMAC) within the IS

  • It strongly colocalizes with Arp3 at the outer ring of the IS, but not with LFA-1 and myosin IIA (which are located in the peripheral SMAC)

  • By stabilizing F-actin, TAGLN2 maintains proper F-actin content at the IS, which is essential for sustained T cell activation following T cell receptor stimulation

TAGLN2 overexpression prolongs T cell spreading and F-actin ring formation on anti-CD3/28–coated surfaces, correlating with increased total F-actin content after stimulation . This stabilization of the actin cytoskeleton at the IS is crucial for proper signal transduction during T cell activation.

What are the molecular mechanisms by which TAGLN2 regulates actin dynamics?

TAGLN2 regulates actin dynamics through several distinct mechanisms:

  • Actin stabilization: TAGLN2 blocks actin depolymerization and competes with cofilin (an actin-severing protein) for binding to F-actin both in vitro and in vivo

  • Dual functionality in actin regulation:

    • Under low-salt conditions, TAGLN2 extensively nucleates G-actin polymerization, which would otherwise be completely suppressed

    • Under physiological salt conditions, TAGLN2 blocks the binding of the Arp2/3 complex to actin filaments, thereby inhibiting branched actin nucleation

  • Mechanical coupling of actin monomers: The calponin homology domain and actin-binding loop of TAGLN2 are essential for mechanically connecting two adjacent G-actins, thereby mediating multimeric interactions

This complex interplay of activities allows TAGLN2 to fine-tune actin dynamics according to the cellular context and physiological requirements.

What is the impact of TAGLN2 deficiency on T cell function?

TAGLN2 knockout (TAGLN2−/−) has significant consequences for T cell function:

  • Reduced F-actin content: TAGLN2−/− T cells show decreased F-actin content and destabilized F-actin ring formation

  • Impaired adhesion and spreading: The absence of TAGLN2 results in decreased cell adhesion and spreading after T cell receptor stimulation

  • Weakened immune responses: TAGLN2−/− T cells display reduced cytokine production, including diminished IL-2 mRNA and protein levels after stimulation with Staphylococcal aureus

  • Impaired cytotoxic function: Effector function is compromised in TAGLN2-deficient T cells, affecting their ability to eliminate target cells

These findings highlight the essential role of TAGLN2 in maintaining proper T cell function through stabilization of the actin cytoskeleton.

How does TAGLN2 regulate phagocytosis in macrophages?

TAGLN2 plays an unanticipated role in Toll-like receptor (TLR)-stimulated phagocytosis:

  • TAGLN2 is significantly induced in macrophages in response to lipopolysaccharide (LPS), a ligand for TLR4, partly through the NF-κB pathway

  • TAGLN2-deficient macrophages (TAGLN2−/−) exhibit defective phagocytic functions against:

    • IgM- and IgG-coated sheep red blood cells

    • Bacterial pathogens

  • Cell signaling pathways involved in actin rearrangement, including PI3 kinase/AKT and Ras-ERK pathways, are down-regulated in LPS-stimulated TAGLN2-deficient macrophages

These findings indicate that TAGLN2 serves as a molecular component of the phagocytic machinery in macrophages, particularly in the context of TLR-mediated activation.

What is the significance of TAGLN2 in host defense against bacterial infection?

TAGLN2 appears to be a critical factor in host defense against bacterial infection:

  • TAGLN2−/− mice show significantly higher mortality after bacterial infection compared to wild-type littermates

  • The increased susceptibility to bacterial infection in TAGLN2-deficient mice correlates with the compromised phagocytic capacity of TAGLN2−/− macrophages

  • TAGLN2 induction in response to LPS suggests that it may be part of the innate immune response to bacterial pathogens

These observations identify TAGLN2 as a molecular armament required for effective host defense against bacterial infections, highlighting its importance in the innate immune response.

What are the key techniques for analyzing TAGLN2 interaction with actin?

Several biochemical and microscopy techniques have been effectively used to study TAGLN2's interaction with actin:

  • High-speed cosedimentation assay: This technique confirms TAGLN2 association with F-actin by recovering TAGLN2 with F-actin in the pellet after centrifugation

  • Fluorescence microscopy: Visualizing GFP-tagged TAGLN2 (TG2_GFP) localization with actin structures in cells provides spatial information about their interaction

  • Coimmunoprecipitation: This approach demonstrates that TAGLN2 binding to actin is stimulus-independent

  • Actin polymerization assay: Using pyrene-labeled actin, this assay compares the polymerizing activity of TAGLN2 with that of other actin-regulating proteins like Arp2/3

  • Critical concentration measurement: This determines whether TAGLN2 affects the concentration of G-actin required for polymerization

These methodologies provide complementary approaches to characterize different aspects of TAGLN2's interaction with actin.

How can researchers effectively study TAGLN2 function in immune cells?

Researchers can employ various approaches to investigate TAGLN2 function in immune cells:

  • Genetic manipulation:

    • TAGLN2 knockout (TAGLN2−/−) mice or cells provide valuable tools for loss-of-function studies

    • TAGLN2 overexpression systems (e.g., J-TG2_GFP cells) allow gain-of-function analyses

    • Deletion mutants (e.g., ΔABM) help identify functional domains

  • Functional assays:

    • T cell spreading and F-actin ring formation on anti-CD3/28–coated surfaces

    • F-actin content measurement by flow cytometry

    • Phagocytosis assays using IgM- and IgG-coated sheep red blood cells or bacteria

    • Cytokine production and cytotoxicity assays

  • Imaging techniques:

    • Live-cell imaging to track TAGLN2 and actin dynamics during IS formation or phagocytosis

    • Fluorescent protein tagging (e.g., GFP, mCherry) to visualize protein localization and interactions

  • Biochemical analyses:

    • Western blot and real-time quantitative PCR to assess expression levels

    • Analysis of signaling pathways (e.g., PI3 kinase/AKT, Ras-ERK) involved in actin rearrangement

These methodological approaches provide a comprehensive toolkit for investigating TAGLN2 function in various immune cell contexts.

How does TAGLN2 coordinate with other actin-binding proteins during immune cell activation?

The interplay between TAGLN2 and other actin-binding proteins represents a complex but important area of research:

  • Competition with cofilin: TAGLN2 competes with cofilin for binding to F-actin both in vitro and in vivo, suggesting a potential regulatory mechanism for controlling actin dynamics at the IS

  • Interaction with Arp2/3 complex: While TAGLN2 blocks Arp2/3 complex binding to actin filaments under physiological salt conditions, their coordinated activities may be essential for forming specific actin structures in immune cells

  • Integration with signaling pathways: TAGLN2 affects signaling pathways involved in actin rearrangement, including PI3 kinase/AKT and Ras-ERK pathways, suggesting potential crosstalk with other cytoskeletal regulators

Future research should focus on mapping the temporal and spatial coordination between TAGLN2 and other actin-binding proteins during immune cell activation, possibly using advanced imaging techniques and protein-protein interaction studies.

What are the therapeutic implications of TAGLN2 in immune-related diseases?

Given TAGLN2's important roles in T cell activation and macrophage phagocytosis, it may have significant implications for immune-related diseases:

  • Immunodeficiency: Since TAGLN2−/− T cells display weakened cytokine production and cytotoxic effector function, TAGLN2 deficiency might contribute to certain immunodeficiency disorders

  • Infection susceptibility: The higher mortality of TAGLN2−/− mice following bacterial infection suggests that TAGLN2 polymorphisms or expression levels might influence susceptibility to infectious diseases

  • Autoimmunity: As TAGLN2 regulates T cell activation, dysregulation of TAGLN2 could potentially contribute to autoimmune conditions by affecting T cell responsiveness

  • Therapeutic targeting: Modulating TAGLN2 function could represent a novel approach for treating certain immune disorders, particularly those involving aberrant T cell activation or defective phagocytosis

Research exploring these therapeutic implications would benefit from population studies examining TAGLN2 polymorphisms in relation to disease susceptibility, as well as preclinical models testing TAGLN2-targeted interventions.

What is the evolutionary significance of TAGLN2 specialization in immune cells?

The evolutionary aspects of TAGLN2 specialization in immune cells present intriguing questions:

  • Phylogenetic analysis shows that the TAGLN family, including TAGLN2, is evolutionarily related to Vav1 and IQGAP1, which are key cytoskeletal-regulatory proteins involved in T cell immunity

  • Tissue-specific expression patterns of the three TAGLN isoforms (TAGLN1 in smooth muscle, TAGLN2 in immune cells, TAGLN3 in brain) suggest functional specialization through evolutionary divergence

  • Conservation across species indicates the fundamental importance of TAGLN2 in immune function throughout vertebrate evolution

Comparative studies of TAGLN2 across different species, particularly focusing on changes in expression patterns and functional domains, could provide insights into how this protein evolved specialized roles in immune cell function. This evolutionary perspective may also inform our understanding of immune system development and the molecular basis of host defense mechanisms.

Product Science Overview

Role in Cancer

Transgelin-2 has been proposed to act as an oncogenic factor, contributing to tumorigenesis in a wide range of human malignancies . Its ability to bind actin suggests that it may influence cell motility and structure, which are critical factors in cancer metastasis . Studies have shown that transgelin-2 is remarkably expressed in bone marrow-derived dendritic cells (BMDCs) during maturation and activation, indicating its potential role in cancer progression .

Role in Immunity

In addition to its oncogenic properties, transgelin-2 also plays a crucial role in the immune system . It is involved in the maturation and activation of dendritic cells, which are essential for initiating immune responses . Transgelin-2 knockout (Tagln2−/−) BMDCs exhibit significant defects in their ability to home to draining lymph nodes and prime T cells to produce antigen-specific T cell clones . These defects are associated with a failure to suppress tumor growth and metastasis in mouse models .

Therapeutic Potential

The therapeutic potential of transgelin-2 has been explored in the context of dendritic cell-based cancer immunotherapy . Non-viral transduction of cell-permeable, de-ubiquitinated recombinant transgelin-2 has been shown to enhance the functions of dendritic cells, thereby suppressing tumor growth and metastasis . This suggests that transgelin-2 can act as a double-edged sword, depending on how it is applied in cancer therapy .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.